149 related articles for article (PubMed ID: 18184082)
1. Failure of TLR4-driven NF-kappa B activation to stimulate virus replication in models of HIV type 1 activation.
Nordone SK; Ignacio GA; Su L; Sempowski GD; Golenbock DT; Li L; Dean GA
AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1387-95. PubMed ID: 18184082
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors required for dermatophagoides farinae to activate NF-κB.
Kitajima T; Muroi M; Yamashita N; Tanamoto K
Biol Pharm Bull; 2014; 37(1):74-80. PubMed ID: 24389483
[TBL] [Abstract][Full Text] [Related]
4. Rac1 and Toll-IL-1 receptor domain-containing adapter protein mediate Toll-like receptor 4 induction of HIV-long terminal repeat.
Equils O; Madak Z; Liu C; Michelsen KS; Bulut Y; Lu D
J Immunol; 2004 Jun; 172(12):7642-6. PubMed ID: 15187145
[TBL] [Abstract][Full Text] [Related]
5. Lipid-associated membrane proteins of Mycoplasma fermentans and M. penetrans activate human immunodeficiency virus long-terminal repeats through Toll-like receptors.
Shimizu T; Kida Y; Kuwano K
Immunology; 2004 Sep; 113(1):121-9. PubMed ID: 15312143
[TBL] [Abstract][Full Text] [Related]
6. Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway.
Bhaskar S; Shalini V; Helen A
Immunobiology; 2011 Mar; 216(3):367-73. PubMed ID: 20828867
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis.
Holle JU; Windmöller M; Lange C; Gross WL; Herlyn K; Csernok E
Rheumatology (Oxford); 2013 Jul; 52(7):1183-9. PubMed ID: 23407387
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 gp120 induces TLR2- and TLR4-mediated innate immune activation in human female genital epithelium.
Nazli A; Kafka JK; Ferreira VH; Anipindi V; Mueller K; Osborne BJ; Dizzell S; Chauvin S; Mian MF; Ouellet M; Tremblay MJ; Mossman KL; Ashkar AA; Kovacs C; Bowdish DM; Snider DP; Kaul R; Kaushic C
J Immunol; 2013 Oct; 191(8):4246-58. PubMed ID: 24043886
[TBL] [Abstract][Full Text] [Related]
9. Repeated lipopolysaccharide (LPS) exposure inhibits HIV replication in primary human macrophages.
Equils O; Salehi KK; Cornateanu R; Lu D; Singh S; Whittaker K; Baldwin GC
Microbes Infect; 2006 Aug; 8(9-10):2469-76. PubMed ID: 16914350
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha-mediated activation of HIV-1 LTR in monocytoid cells by mycobacteria.
Kitaura H; Ohara N; Kobayashi K; Yamada T
FEMS Immunol Med Microbiol; 2001 Aug; 31(2):97-103. PubMed ID: 11549416
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation.
Equils O; Shapiro A; Madak Z; Liu C; Lu D
Antimicrob Agents Chemother; 2004 Oct; 48(10):3905-11. PubMed ID: 15388451
[TBL] [Abstract][Full Text] [Related]
12. Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication.
Marr N; Turvey SE
Innate Immun; 2012 Dec; 18(6):856-65. PubMed ID: 22535679
[TBL] [Abstract][Full Text] [Related]
13. Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.
Bolduc JF; Ouellet M; Hany L; Tremblay MJ
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928019
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells.
Alvarez-Carbonell D; Garcia-Mesa Y; Milne S; Das B; Dobrowolski C; Rojas R; Karn J
Retrovirology; 2017 Feb; 14(1):9. PubMed ID: 28166799
[TBL] [Abstract][Full Text] [Related]
15. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
16. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of LPS-induced HIV type I activation in transgenic mouse macrophages.
Kadoki M; Choi BI; Iwakura Y
Int Immunol; 2010 Jun; 22(6):469-78. PubMed ID: 20504885
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages.
González OA; Li M; Ebersole JL; Huang CB
Clin Vaccine Immunol; 2010 Sep; 17(9):1417-27. PubMed ID: 20610663
[TBL] [Abstract][Full Text] [Related]
19. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
20. Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling.
Ando K; Hasegawa K; Shindo K; Furusawa T; Fujino T; Kikugawa K; Nakano H; Takeuchi O; Akira S; Akiyama T; Gohda J; Inoue J; Hayakawa M
FEBS J; 2010 May; 277(9):2051-66. PubMed ID: 20345905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
